To confirm the hypothesis that senescent cells can impact the cytotoxicity of sorafenib in neighboring non-senescent HCC cells through secreting IL6, parent HepG2 cells and the cells with p16 overexpression were co-cultured in a transwell chamber. Here, CDKN2A is linked to hepatocellular carcinoma.